NeuroQuant Brain Tumor is an FDA-cleared software solution designed to provide radiologists with accurate, automated measurements of brain tumors. By reducing variability and enhancing precision, it helps streamline the quantification process for high-grade and low-grade glioblastomas, providing critical data without the manual workload.
NeuroQuant Brain Tumor leverages advanced AI to automate tumor segmentation and volumetric analysis directly from MRI scans. This automation eliminates the time-consuming and manual measurements traditionally performed by clinicians. By ensuring consistent, accurate tumor quantification, NeuroQuant Brain Tumor supports more informed decision-making in both diagnostics and treatment.
NeuroQuant Brain Tumor offers valuable support for the entire treatment journey, from diagnosis to follow-up care. Clinicians can use it to track changes in tumor volume over time, providing critical insights into treatment efficacy. This not only improves consistency but significantly reduces the time required to assess tumor volume. The tool offers both 2D and 3D measurements, providing detailed insights into tumor size and progression while adhering to RANO (Response Assessment in Neuro-Oncology) guidelines.
By delivering precise volumetric data, NeuroQuant Brain Tumor aids in surgical planning and post-surgical evaluations. The detailed imaging supports personalized treatment plans, particularly for patients undergoing aggressive therapies or those requiring close monitoring of slow-growing tumors. Its ability to generate 3D visualizations offers a clear view of tumor dynamics, which helps optimize both treatment planning and follow-up care.
NeuroQuant Brain Tumor is a trusted tool in clinical settings for accurately quantifying and tracking brain tumors. Its ability to reduce variability, save time, and improve diagnostic precision makes it an invaluable asset for clinicians dedicated to delivering optimal care for patients with brain tumors.
To explore how NeuroQuant Brain Tumor can enhance your clinical practice, schedule a demo today. Experience firsthand the impact of reliable, automated tumor quantification and see how it supports better treatment outcomes.
